** Shares of protective face mask maker APT.A jump 26.3%
to $20 - on track to extend a more than six-fold gain YTD
** Stock has now gained in the past 7 of 9 sessions
** Shares of other companies developing treatments and
vaccines for the coronavirus were down after a rally in
February; Vaxart Inc VXRT.O , Novavax Inc fell 10%-15%, test
maker Co-Diagnostics Inc CODX.O was down ~8%
** U.S. health agencies on Monday said they had taken action
to make more respirators, including N-95 masks, available to
healthcare personnel as the coronavirus outbreak which
originated in China spreads abroad
** The actions allow certain approved respirators not
regulated by the FDA to be used in a healthcare setting by
medical workers
** APT on Feb. 27 said demand for its N-95 facemasks
remained strong and it was ramping up production urn:newsml:reuters.com:*:nL2N2AR1A5
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709;))